Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: LONG NAGOMI™ PMCF STUDY

View source ↗

Summary

This clinical trial update notes that the LONG NAGOMI PMCF study, sponsored by Fundación EPIC, is currently recruiting in patients with coronary artery disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease, Ischemic Heart Disease | Status: RECRUITING